Характеристика интерферон-альфа-индуцированных дендритных клеток и их терапевтический потенциал в лечении онкологических и инфекционных заболеваний
Диссертация
Исследование ИФН-ДК у больных онкологическими и инфекционными заболеваниями показало принципиальную возможность получения этих клеток в культуре in vitro. Тем не менее, при ряде патологий генерируемые ДК отличались признаками задержки дифференцировки и созревания, что проявлялось увеличением в популяции ИФН-ДК клеток с фенотипом незрелых ДК и ДК промежуточной степени зрелости (CD14+, CDla… Читать ещё >
Список литературы
- Бирюкова М.С. Эндокринные заболевания и синдромы. Вирилизм//
- Знание -М, Москва. 2000. — С. 165.
- Качалина Т.С. Гиперандрогения и невынашивание беременности // Российский вестник акушера гинеколога. — 2004. — № 3.
- Лозовой В.П., Кожевников B.C. Методы оценки клеточных эффекторных функций гиперчувствительности замедленного типа //Методические рекомендации. Москва, 1990. — С.1−10.
- Селедцова Н.В., Хонина Н.А, Дударева А. В, Тихонова М. А., Останин А. А, Пасман Н. М., Черных Е. Р. Нарушение иммунорегуляторных механизмов у беременных с гиперандрогенией // Бюлл. СО РАМН.2006.-№ 1 (119).- С.35−40.
- Селедцова Н.В., Хонина H.A., Тихонова М. А., Останин A.A., Пасман Н. М., Черных Е. Р. Влияние дегидроэпиандростерона сульфата на фенотип и функции дендритных клеток in vitro// Мед. иммунология.2007.- Т. 9, № 6. С 589−596.
- Хонина Н.А., Центнер М. И., Леплина О. Ю., Тихонова М.А., Ступак
- B.В., Никонов С. Д., Черных Е. Р., Останин А. А. Характеристика и механизмы иммунных нарушений у больных со злокачественными опухолями головного мозга// Вопросы онкологии. 2002.- Т. 48, № 2 .1. C.196−201.
- Черных Е.Р., Сахно Л. В., Хонина Н. А., Тихонова М.А., Кожевников
- B.C., Никонов С. Д., Жданов О. А., Останин А. А. Субпопуляционная принадлежность Т-клеток, подверженных анергии и апоптозу, у больных туберкулезом легких// Проблемы туберкулеза. 2002. — № 7.1. C.43−48.
- Abediankenari S, Shaker D, Abedian F, Mirabi A. The effect of beta interferon on dendritic cells and cytokine synthesis by CD4+ T cells// Iran J Immunol. 2009 V. 6(2). — P.61−66.
- Akasaki Y., Kikuchi Т., Homma S., Abe Т., Kofe D., Ohno T. Antitumor effect of immunizations with fusions of dendritic and glioma cells in amouse brain tumor model// J Immunother. 2001 — V.24.- P. 106−113.
- Akbar S.M., Furukawac S., Hasebe A, Horiike N., Michitaka K., Onji. M. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrier// Int. J. Mol. Med. 2004. — V.14. -P. 295−299.
- Almand B, Resser J. R, Lindman B., Nadaf S., Clark J.I., Kwon E.D., Carbone D.P., Gabrilovich D.I. Clinical significance of defective dendritic cell differentiation in cancer// Clin Cancer Res. 2000. — V.6. — P. 17 551 766.
- Askelund K., Liddell H.S., Zanderigo A.M., Fernando N.S., Khong T.Y., Stone P.R., Chamley L.W. CD83+dendritic cells in the decidua of womenwith recurrentmiscarriage and normal pregnancy// Placenta. 2004. — V.25.- P.140 -145.
- Aspinall R. Ageing and the immune system in vivo// Immunity & Ageing. -2004. V.2. — P.5.
- Auffermann-Gretzinger S., Keeffe E.B., Shoshana L.S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection//Blood. -2001. V.97, N.10. — P.3171−3176.
- Austin J.M., Phil D. Dendritic cells// Curr.Opin.Hematol. 1998. — V.5. -P.3−15.
- Bachy V., Williams D.J., Ibrahim M.A. Altered dendritic cell function in normal pregnancy// J Reprod Immunol. 2008. — V. 78, N 1. — P. 11−21.
- Banchereau J., Steinman R.M. Dendritic cells and control of immunity// Nature.-1998.- V.392. P.245−252.
- Belardelli F. Role of interferons and other cytokines in the regulation of the immune response//APMIS (Acta. Pathol. Microbiol. Immunol. Scand.) -1995. V.103.- P.161−179.
- Belkaid Y., Oldenhove G. Tuning microenvironments: induction of regulatory T cells by dendritic cells// Immunity- 2008.- V. 29.- P.362−371.
- Bellone S, Pecorelli S, Cannon MJ, Santin AD. Advances in dendritic-cell-based therapeutic vaccines for cervical cancer// Expert Rev Anticancer Ther.- 2007 .-V.10.-P.1473−1486.
- Bender A., Sapp M., Shuler G., Steinman R., Bhardway N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood// J.Immunol.Methods. 1996. -V. 196.-P. 121 135.
- Benson M.J., Pino-Lagos K., Rosemblatt M., Noelle, R.J. Alltransretinoic acid mediates enhanced T reg cell growth, differentiation, andgut homing in the face of high levels of co-stimulation// J. Exp. Med. 2007. — V.204. -P. 1765−1774.
- Berzofsky J.A., Terabe M., Oh S.K., Belyakov I.M., Ahlers J.D., Janik J.E. Morris J.C. Progress on new vaccine strategies for the immunotherapy andprevention of cancer//J. Clin. Invest. 2004.-V. 113.- P. 1515−1525.
- Billerbeck E., Blum H.E., Thimme R. Parallel expansion of human virus-specific F0XP3- effector memory and de novo-generated FOXP3+ regulatory CD8+ T cells upon antigen recognition in vitro// Immunol.-2007, — V.179.- P.1039−1048.
- Boczkowski D., Nair S.K., Snyder D., Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo// J Exp Med. -1996. V.184. — P.465−472.
- Bogdan C. The function of type 1 interferons in antimicrobial immunity// Curr.Opin.Immunol. 2000. — V.12. — P.419−424.
- Brimnes M. K, Svane I. M, Johnsen H. E. Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma// Clinical and Experimental Immunology. V. 144. — P.76−84.
- Butch A.W., Kelly K.A., Munshi N.C. Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein // Exp. Hematology.- 2001.- V.29, N.l. P. 85−92.
- Butts, C. L., Shukair, S.A., Duncan, K. M., Harris, C. W., BelyanporaBkaya, E., Sternberg, E. M. Effects of dexamethasone on rat dendritic cellfunction.// Horm. Metab. Res 2007- V. 39. — P.404112.
- Canning M.O., Grotenhuis K., de Wit H.J., Drexhage H.A. Opposing effects of dehydroepiandrosterone and dexamethasone on the generation ofmonocyte-derived dendritic cells// Eur J Endocrinol.- 2000. V. 143. — № 5. — P.687 — 695.
- Cella M., Jarrosay D., Facchetti F. Plasmocytiod monocytes migrate to inflamed lymph nodes and produce large amount of type I interferon.// Nat. Med. 1999. — V.5. — P.919−923.
- Celluzzi C.M., Mayordomo J.I., Storkus W.J., Lotze M.T., Falo L.D. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity// J Exp Med. 1996. — V.183. — P.283−287.
- Chang A.E., Redman B.G., Whitfield J.R., Nickoloff B. J, Braun T. M, Lee P. P, Geiger J. D, Mule J.J. A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer// Clin Cancer Res.- 2002. V. 8. -P.1021−1032.
- Chang D.M., Chu S.J., Chen H.C., Kuo S.Y., Lai J.H. Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus// Ann Rheum Dis. 2004. — V.63. — N 12. -P. 1623 — 1626.
- Chaperot L., Blum A., Manches O., Lui G., Angel J., Molens J. P., Plumas J. Virus or TLR agonists induce TRAIL-mediated cytotoxic activity ofplasmacytoid dendritic cells //J Immunol. 2006.- V.176.- P. 248−255.
- Chapoval A., Tamada K., Chen L. In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells// Blood. -2000. V. 95 (7). — P.2346−2351.
- Chauvin C., Josien R. Dendritic cells as killers: mechanistic aspects and potential roles// J. Immunol. 2008. — V. 181. — P. 11−16.
- Chen C.C., Parker C.R. Adrenal androgens and the immune system// Jr Semin Reprod Med. 2004. — Y.22. — N 4. — P.369−377.
- Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity// Nat. Rev. Immunol.- 2004.- V.4.- P.336−347.
- Cho Y.S., Challa S., Clancy L., Chan F.K. Lipopolysaccharide-induced expression of TRAIL promotes dendritic cell differentiation// Immunology.-2010.-V.130.-P 504−515.
- Choi I. S., Cui Y., Koh Y-A., Lee H-C., Cho Y-B., Won Y-H. Effects ofdehydroepiandrosterone on Th2 cytokine production in peripheral blood mononuclear cells from asthmatics// The Korean Journal of Internal Medicine. 2008. — V.23. — P. 176 -181.
- Choi C., Jeong, E., Benveniste E. Caspase-1 Mediates Fas-Induced Apoptosis and is Up-Regulated by Interferon-y in Human Astrocytoma Cells// Journal of Neuro-Oncology. 2004. — V.67, N. l-2. — P. 167−176.
- Cox K., North M., Burke M., Singhal H., Renton S., Agel N., Islam S., Knight S.C. Plasmacytoid dendritic cells (PDC) are the major DC subset innately producing cytokines in human lymph nodes// J. Leukoc. Biol. -2005. -V.75.-P.1142−1152.
- Curotto de Lafaille M.A., Kutchukhidze N., Shen S., Ding Y., Yee H., Lafaille J.J. Adaptive Foxp3+ regulatory T cell-dependent and -independentcontrol of allergic inflammation// Immunity -2008.-V. 29. -P.l 14−126.
- Delia Bella S., Nicola S., Riva A., Biasin M., Clerici M., Villa M.L. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-a//J.of Leukocyte Biology.- 2004. -V. 75. P.106−116.
- Delia Bella S, Nicola S, Brambilla L, Riva A., Ferrucci S., Presicce P., Boneschi V., Berti, E., Villa M. L. Quantitative and functional defects of dendritic cells in classic Kaposi’s sarcoma// Clinical Immunology 2006 -V.l 19. -P.317−329.
- Dhodapkar M.V., Steinman R.M., KrasonpoTHBky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells// J Exp Med. 2001. -V.l93. — P.233−238.
- Dieckmann D., Bruett C.H., Ploettner H., Lutz M.B., Schuler G. Human CD4+CD25+ regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1 -like regulatory T cells// J. Exp. Med.- 2002.- V.196. N 2.- P. 247−253.
- Dieu-Nosjean M.C., Vican A., Lebecque S., Caux C., Regulation of dendritic cell traffic: a process that involves the participation of selective chemokines//J.Leuc.Biol. 1999. — V.66. — P.252−262.
- Do T.H., Johnsen H.E., Kjaersgaard E., Taaning E., Svane I.M. Impaired circulating myeloid DCs from myeloma patients// Cytotherapy. 2004. -V.6.-P. 196−203.
- Dong H., Chen L. Immunoregulatory role of B7-H1 in chronicity of inflammatory responses// Cell Mol.Biol. 2006. — V.3. — P. 179−187.
- Dong H., Chen L. B7-H1 pathway and its role in the evasion of tumor immunity// Mol. Med. 2005. — V 81. — P.281−287.
- Dosiou C., Giudice L.C. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives// Endocrine Reviews. 2005. — V. 26.- P.44−62.
- Dosiou C., Ida H., Utz P.J., Anderson P., Eguchi K. Granzyme B and natural killer cell death// Mod Rheumatol. 2005. — V.15.- P.315−322.
- Driessens G., Hamdane M., Cool V., Velu T., Bruyns C. Highly Successful Therapeutic Vaccinations Combining Dendritic Cells and Tumor Cells Secreting Granulocyte Macrophage Colony-stimulating Factor// Cancer Research. 2004. — V.64. — P.8435−8442.
- Duan X.Z., Wang M., Li H.W., Liu J.C., Wang F.S. Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection// J. Gastroenterol. Hepatol.- 2005.- V. 20.-P.234−242.
- Enomoto M, Nagayama H, Sato K., Xu Y, Asano S, Takahashi TA. In vitro generation of dendritic cells derived from cryopreserved CD34 cellsmobilized into peripheral blood in lymphoma patients// Cytotherapy. -2000.-V.2.-P.95−104.
- Fanger N.A., Maliszewsky C.R., Schooley K., Griffith T.S. Human dendritic cell mediate cellular Apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)// J.Exp.Med.-1999.- V.190. P. 11 551 164.
- Faria A.M., Weiner H.L. Oral tolerance// Immunol. Rev. 2005. — V. 206. -P.232−259.
- Farkas A., Tonel G., Nestle F.O. Interferon-a and viral triggers promote functional maturation of human monocyte-derived dendritic cells// Br J Dermatol. 2008- V. 158.-P. 921−929.
- Farkas L., Beiske K., Lund-Johansen F. et all. Plasmacytoid dendritic cells accumulate in cutaneus lupus erythematosus lesions// Am. J Phathology.2001.-V.l 59.-P.23 7−243.
- Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management// J Am Acad Dermatol. 2007. — V.5. — P.737−763.
- Fedoric B, Krishnan R. Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction// Immunol. Lett. -2008 -. V. 120.-P.49−59.
- Fong L., Engleman E.G. Dendritic cells in cancer immunotherapy// Annu. Rev. Immunol.- 2000.- V. l8.- P.245−273.
- Friec G. L, Gros F, Sebti Y., Guilloux V, Pangault C, Fauchet R, Amiot L. Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules// J. Leukoc. Biol. 2004. -V. 76.-P. 1125−1133.
- Gardner L., Moffett A. Dendritic cells in the human deciduas// Biol Reprod. -2003.-V.69.-P. 1438- 1446.
- Gauzzi M.C., Canini I., Eid P., Belardelli F., Gessani. S. Loss of type I IFN-reseptors and impaired responsiveness during terminal maturation of monocytes-derived human dendritic cells// J.Immunol. 2002. — V.169. -P.3038−3045.
- Geijtenbeek T.B., van Vliet S.J., Koppel E.A., Sanchez-Hernandez M., Vandenbroucke-Grauls C.M., Appelmelk B., van Kooyk V. Mycobacteria target DC-SIGN to suppress dendritic cell function// J. Exp. Med. 2003. -V.197. -P.7−17.
- Gerlini G., Mariotti G., Chiarugi Gerlini A. Induction of CD83+CD14+ nondendritic antigen-presenting cells by exposure of monocytes to IFN-alpha // J Immunol. 2008. -Vol 181, N 5. — P. 2999 — 3008.
- Greenwald R.J., Boussiotis V.A., Lorsbach R.B., Abbas A.K., Sharpe A.H. CTLA-4 regulates induction of anergy in vivo// Immunity. 2001. — V.14. -P.145−155.
- Guerin L.R., Prins J.R., Robertson S.A. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment// Human Reproduction Update.- 2009.- V. l, N. 1.- P. l-19.
- Hanekom W.A., Mendillo M., Manca C., Haslett P.A., Siddiqui M.R., Barry C., Kaplan G. Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro// J. Infect. Diseases. 2003. -V.l88. -P.257−266.
- Hardy A.W., Graham D.R., Shearer G.M., Herberval J.P. HIV turns plasmacytoid dendritic cells into TRAIL-expressing kiler pDC and down-regulates HIV conception by TLR7-indused IFN-a// Proc.Natl.Acad.Sci. USA. 2007. — V. l04. — P. 17 453−17 458.
- Hart D.N.J. Dendritic cells: unique leukocyte population which control the primary immune response// Blood. 1997. — V.90. — P.3245−3287.
- Hayakawa Y., Screpanti V., Yagita H., Grandien A., Ljunggren H-G., Smyht M.J., Chambers B.J. NK cell TRAIL eliminates dendritic cells in vivo and limits dendritic cell vaccination efficacy// J. of Immunol. 2004. -V.172. — P.123−129.
- Heimberger A. B, Crotty L.E., Archer G.E. Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma//J. Neuroimmunol. 2000.- V.103. — P. 16−25.
- Herrmann J.L., Tailleux L., Nigou J., Giquel B., Puzo G. The role of human dendritic cells in tuberculosis: protector or non-protector?// Rev. Mai. Respir.- 2006.- V.3.- P.621−628.
- Hsu FJ, Benike C, Fagnoni F et al. Vaccination of patients withB-cell lymphoma using autologous antigen pulsed dendritic cells// Nat Med. -1996. V.2. — P.52−58.
- Huang S.J., Chen C.P., Schatz F., Rahman M., Abrahams V.M., Lockwood C.J. Pre-eclampsia is associated with dendritic cell recruitment into the uterine deciduas// J Pathol. 2008. — V.214, N 3. — P.328−336.
- Insug O., Ku G., Ertl H.C., Blaszczyk-Thurin M. A dendritic cell vaccine induces protective immunity to intracranial growth of glioma// Anticancer Res. 2002. — V. 22. — P.613−621.
- Ito T., Amakawa R., .Inaba M., Ikehara S., Inaba K., Fukuhara S.
- Differential regulation of human blood dendritic cell subsets by INFs // J Immunol.- 2001.- V.166.- P. 2961−2969.
- Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses// Nat Immunol. 2004. — V 5. — P. 987−995.
- Janjic B.M., Pimenov A., Whiteside T.L. Storkus W.J., Vujanovic N.L. Innate direct anticancer effector function of human immature dendritic cells. I. Involvement of an apoptosis-inducing pathway// J. Immunol.- 2002.-V.168.- P.1832−1840.
- Jiang M., Liu Z., Xiang Y, Ma H, Liu S., Liu Y., Zheng D. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma //BMC Cancer. 2011. -11:54.
- Jonulait H., Weidemann K., Muller G. Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells a role for IL-15 in attraction of N-cells// J.Immunol. — 1997. — V.158. — P.2610−2615.
- Jonuleit N.K., Wiedemann G., Muller J., Degwert U., Hoppe J., Knop J., Enk A.N. Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: a role for IL-15 in attraction of T-cells// J.Immunol. 1998. — V.158. — P.2610−2615.
- Joo H., Fleming T., Tanaka Y., Dunn T., Linehan D., Goedegebuure P., Eberlein T. Human dendritic cells induce tumor-specific apoptosis by soluble factors// International Jurnal of Cancer.-2002.-V.102. P.20−28.
- Juretic K., Strbo N., Crncic T.B., Laskarin G., Rukavina D. An insight intothe dendritic cells at the maternal-fetal interface // Am J Reprod Immunol. -2004. Vol 52. — P.350 — 355.
- Jun S., Ikeda K., Maeda Y., Shinagawa K., Ohtsuka A., Yamamura H., Tanimoto M. Identification of CD 123+ myeloid dendritic cells as anearly-stage immature subset with strong tumoristatic potential// Cancer Letters.-2008.-V.270.- P. 19−29.
- Kammerer U., Kruse A., Barrientos G., Arck P.C., Blois S.M. Role of dendritic cells in the regulation of maternal immune responses to the fetus during mammalian gestation // Immunol Invest. 2008. — V.37, N 5. — P. 499−533.
- Kanto T., Takenara T. Immunopathogenesis of type C hepatitis: dendritic cell in HCV infection// J. Gastroenterol. Hepatol.- 2004.- V. 19.- S.(7) P. S84-S87.
- Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization // Nature Rev. Immunol. 2003. — V.3. — P.984−993.
- Kikuchi T., Akasaki Y., Irie M. Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells//Cancer Immunol Immunother. 2001.- V.50. — P.337−344.
- Knight M., Riffkin C., Muscat A., Ashley D., Hawkins C. (2001). Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells// Oncogene. -2001. V.20. -P.5789−5798.
- Knoechel B., Lohr J., Kahn E., Bluestone J.A., Abbas A.K.2005). Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen// J. Exp. Med. 2005. — V.202. — P.1375−1386.
- Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., DeMars, R. A class I antigen, HLA-G, expressed in human trophoblasts // Science. -1990.-V. 248.-P. 220−223.
- Koul A., Herget T., Klebl B., Ullrich A. Interplay between mycobacteria and host signaling pathways// Nature Rev Microbiol.- 2004, — V.2.- P. 189 202.
- Krishnadas D.K., Ahn J.S., Han J., Kumar R., Agrawal B. Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms//Int. Immunol. 2010. — V. 22(6). -P. 491−502.
- Laskarin G., Redzovic A., Rubesa Z., Mantovani A., Allavena P., Haller H., Vlastelic I., Rukavina D. Decidual natural killer cell tuning by autologous dendritic cells// Am J Reprod Immunol. 2008. — V.59, N.5. — P.433−445.
- Le Friec G., Gros F., Sebti Y. Guilloux V, Pangault C, Fauchet R, Amiot L. Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules// J. Leukoc. Biol.- 2004.-V.76.- P.1125−1133.
- Le Maoult G., Krawice-Radanne I., Dausset J., Carosella E.D. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells // Proc. Natl. Acad. Sci. USA.- 2004.- V. 101.- P.7064−7069.
- Le Poole C, El-Masri W.M., Denman C.J., Krol T. M, Bommiasamy H, Eiben G.L., Kast W.M. Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells// Cancer Immunol Immunother. 2008. — V. 57. — P.789−797.
- Lefebvre S., Antoine M., Uzan S., McMaster M., Dausset J., Carosella E.D.,
- Paul P. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT-2 inhibitoryreceptor in human breast cancer// J. Pathol. 2002. — V 196. — P. 266−274.
- Liau L.M., Black K.L., Prins R.M. Sykes S. N, DiPatre P. L, Cloughesy T.F. Treatment of intracranial gliomas with bone-marrow-derived dendritic cells pulsed with tumor antigens // J.Neurosurg.-1999.-Vol.90.-P.l 115−1124.
- Lim D-S., Kang M-S, Jeong J-A, Bae Y-S. Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice// European Journal of Immunology.- 2009. -V.39. P.1334−1343.
- Lincz L.F., Yeh T-X., Spencer A. TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to
- TRAIL receptor expression or prior chemotherapy Leukemia. 2001. -V.15. — P.1650−1657.
- Lipscomb M.F., Masten K. Dendritic cells: Immune regulators in health and disease// Physiol.Rew. 2002. — V.82.- P.97−130.
- Liu S., Yu Y., Zhang M., Wang W., Cao X. The involvement of TNF-alpha-related apoptosis inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells// J Immunol.- 2001.- V.166.-P. 5407−5415.
- Liu Y.Y., Yang N., Kong L.N., Zuo P.P. Effects of 7-oxo-DHEA treatment on the immunoreactivity of BALB/c mice subjected to chronic mild stress// Yao Xue Xue Bao. 2003. — V.38. — N12. — P.881- 884.
- Lopez M.R., Moser M. Dendritic cell subsets and the regulation of Thl/Th2 Responses// Seminars in Immunology. -2001. Y.13. — P.275−282.
- Lu W.L., Arraes C., Ferreira W. T, Andrieu J.M. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection// Nat. Med. 2004. — V.10. — P. 13 591 365.
- Luft T., Luetjens P., Hochrein H., Toy K.-A., Masterman M., Rizkalla E., Cebon, J. Type I IFNs enhance the terminal differentiation of dendritic cells// J. Immunol. 1998. — V. 161.- P. 1947−1953.
- Lukens J.R., Cruise M.W., Lassen M.G., Hahn Y.S. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model// J. Immunol.- 2008.- V.180.- P. 4875−4884.
- Luo J., Li J., Chen R. L., Nie L., Huang J., Liu Z. W., Luo L., Yan
- XJ. Autologus dendritic cell vaccine for chronic hepatitis В carriers: A pilot, open label, clinical trial in human volunteers// Vaccine. 2010. — V. 28. — P. 2497−2504.
- Lutz M.B., Schuler G. Immature, semi-mature, and fully mature dendritic cells: Which signals induce tolerance or immunity?// Trends Immunol. -2002.-V.23.-P. 445−449.
- Luykx-de Bakker S.A., de Gruijl T.D., Sheper R.J., Wagstaff J., Pinedo H.M. Dendritic cells: a novel therapeutic modality// Ann.Oncol. 1999. -V.10. -P.21−27.
- Maier H., Isogawa M., Freeman G.J., Chisari F.V. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver// J. Immunol.- 2007.- V.178.- P. 2714−2720.
- Manna P., Mohanakumar T. Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro// Journal of Leukocyte Biology. -2002.-V.72.-P.312−320.
- Mariand G., Bakker A.B., Adema G.J., Figdor C.G. Dendritic cells in immune responcse induction//Stem Cells. 1996. — V.14. — P.501−507.
- Markawitcz S., Engleman E.G. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro// J.Clin.Invest. 1990. — V.85. — P.955−961.
- Massard G., Tongia M-M., Wihin J-M., Morand G. The dendritic cell lineage: a ubiquitous antigen-presenting organization// Ann.Thorac.Surg. -1996. V.61. -P.252−258.
- Mcllroy D., Gregoire M. Optimizing dendritic cell-based anticancer immunotherapy maturation state does have clinical impact// Cancer Immunol. Immunother. — 2003 .- V.52. — P.583−591.
- Miranda S., Litwin S., Barrientos G., Szereday L., Chuluyan E., Bartho J.S., Arck P.C., Blois S.M. Dendritic cells therapy confers a protective microenvironment in murine pregnancy// Scand J Immunol. 2006. — V.64, N 5. — P.493 — 499.
- Mogensen K.E., Lewerenz M., Reboul J., Lutfalla G., Uze G. The type I Interferon receptor: structure, function and evolution of a family business// J. Interferon Cytokine Res. 1999. — V.19. — P. 1069−1098.
- Mohty M., Isnardon D, Vey N., Briere F., Blaise D., Olive D, Gaugler. Lowblood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34/CD38 primitive haematopoietic progenitors // Br J Hematol.-2002.- V. l 19.- P.115−118.
- Moser M., Murphy K.M. Dendritic cell regulation of Thl-Th2 development// Nat. Immunol. 2000. — V 1. — P. 199−205.
- Munn D.H. Tolerogenic Antigen-Presenting Cells// Annals NYAS Online. -2002.-V.961.-P. 343−345.
- Murakami H., Akbar S.M.F, Matsui H., Horike N., Onji M. Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C// Clin. Exp. Immunol.-2004.- V.137.- P.559−595.
- Namazi M.R. The Thl-promoting effects of dehydroepiandrosterone can provide an explanation for the stronger Thl-immune response of women // Iran J Allergy Asthma Immunol.-2009. V.8, N1. — P.65 -69.
- Ni H.T., Spellman S.R., Jean W.C., Hall W.A., Low W.C. Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas// JNeurooncol-2001 -V. 51.-P. 1−9.
- Osugi Y., Vuckovic S., Hart D. N. J. Myeloid blood CD1 lc+ dendritic cellsand monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes // Blood. 2002. — V.100. — P.2858−2866.
- Pahlavani M.A., Harris M.D. Effect of dehydroepiandrosterone on mitogen-induced lymphocyte proliferation and cytokine production in young and old F344 rats// Immunol Lett. 1995. — Vol.47. — N. l-2. — P.9−14.
- Pangault C., Le Friec G., Caulet-Maugendre S., Lena, H., Amiot L., Guilloux V., Onno M., Fauchet R. Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases// Hum. Immunol. 2002-V.- 63. — P 83−90.
- Panner A., James C., Berger M., Piepe R. mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells// Mol Cell Biol. -2005. V.25. — P. 8809−8823.
- Paquette R. L, Hsu N., Said J., Mohammed M., Rao N.P., Shih G., Schiller G., Sawyers C., Glaspy J.A. Interferon-induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo// Leukemia. 2002. — V. 16. -P. 1484−1489.
- Parlato S., Santini S., Lapenta C., Di Pucchio T., Logozzi M., Spada M., Giammarioly A., Malorni W., Fais S., Bellardelli F. Expression of CCR-7,
- MIP-3b, and Thl chemokines in type I IFN-induced monocyte-derived dendritic cells importance for the rapid acquisition of potent migratory and functional activities// Blood.- 2001.- V.98. — P. 3022−3029.
- Parney I., Hao C., Petruk, K. Glioma immunology and immunotherapy // Neurosurgery. 2000. — V.46. — P. 778−791.
- Peters J.H., Gleseler R., Thiele B., Steinbach F. Dendritic cells from ontogenetic orhans to myelomonocytic descendants// Immunol. Today. -1996. V.17. -P.273−278.
- Pinzon-Charry A., Maxwell T., Lopez J.A. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression // Immunol Cell Biol.- 2005.-V. 83.- P.451r461.
- Pitti R. M, Marsters, S.A., Ruppert, S., Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family// J. Biol. Chem. 1996. — V.271.- P.12 687−12 693.
- Pollard J. W. Uterine DCs are essential for pregnancy// J. Clin. Invest. -2008. V.118 — P.3832−3835.
- Powell J.M., Sonnenfeld G. The effects of Dehydroepiandrosterone (DHEA) on in vitro spleen cell proliferation and cytokine production// J Interferon & Cytokine Research. 2006.- V. 26, N 1.- P.34−39.
- Qin S., Rottman J-B., Myers P. The chemokine reseptors CXCR3 and CCR5 mark subsets of T-cells associated with certain inflammatory reactions// J.
- Clin.Invest. 1998. — V. 101. — P.746−754.
- Radford K.J., Vari F., Hart D.N. Vaccine strategies to treat lymphoproliferative disorders// Pathology. 2005.- V.37. — P.534−550.
- Rapp M., Ozean Z., Steiger H.J., Werhet P., Sabel M.C., Sorg R.V. Cellular immunity of patients with malignant gliomaiprerequisites for dendritic cell vaccination immunotherapy// J.Neurosurgery.- 2006.-V.105.- P.41−50.
- Redmond G.P. Androgens and women’s health// Int J Fertil. 1998. — V.43. — P.91−97.
- Rehermann B., Fowler P., Sidney J et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis// J Exp Med. 1995. — V.181. — P.1047−1058.
- Riboldi E., Daniele R., Cassatella M., Sozzani S., Bosisio D. Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells// Immunobiology. 2009. — V.214. — P. 868−876.
- Rissoan M.C., Soumelis V., Kadovaki N., Grouard G., Briere F., de Waal Malefyt R., Liu Y.J. Reciprocal control of T-helper cell and dendritic cell differentiation// Science.- 1999. V.283. -P.l 183−1186.
- Ritchie D. S, Quach H., Fielding K., Neeson P. Drug-mediated and cellular immunotherapy in multiple myeloma//Immunotherapy. 2010. — V.2, N.2. -P 243−255.
- Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P., Steiman R., Schuler G. Proliferating dendritic cells progenitors in human blood// J.Exp.Med.-1994- V.180. P.83−93.
- Roncarolo M.G., Gregori S., BattagliaM., Bacchetta R., Fleischhauer K., Levings M.K. Interleukin-10-secreting type 1 regulatory T cellsin rodents and humans// Immunol. Rev. 2006. — V.212. — P.28−50.
- Salomon B., Bluestone J.A. Complexities of CD28/B7:CTLA-4 costimulatory pathway in autoimmunity and transplantation// Annu. Rev. Immunol. 2001. — V.9. — P.225−253.
- Santini S., Belardelli F. Advances in the use of dendritic cells and new adjuvants for the development of therapeutic vaccines// Stem cells. 2003. -V.21.-P. 495−505.
- Santini S., Lapenta C., Logozzi M., Parlato S., Spada M., Di Pucchio T.,
- Bellardelli F. Type I Interferon as a powerful adjuvant for monocyte-derived dendritic cells development and activity in vitro and in HU-PBL-SCID mice//J. Exp. Med.-2000.-V.191. -P.1777−1788.
- Santini S., Pucchini T., Lapenta C., Parlato S., Logozzi M., Belardelli F. A new type 1 IFN-mediated pathway for the rapid differentiation of monocytes into highly active dendritic cells // Stem cells. 2003. — V. 21. — P. 357−362
- Santini S.M., Di Pucchini T., Lapenta C. The natural alliance between type I IFN and dendritic cells and its role in linking innate and adaptive immunity// interferon Cytokine Res. 2002. — V.22. — P. 1071−1080.
- Santini S. M, Lapenta C., Belardelli F. Type I interferons as regulators of the differentiation/activation of human dendritic cells: methods for the evaluation of IFN-induced effects// Methods Mol Med.-2005.-V. 116-P. 167−181.
- Santini S.M., Lapenta C., Santodonato L., D’Agostino G., Belardelli F., Ferrantini M. IFN-alpha in the generation of dendritic cells for cancer immunotherapy// Handb Exp Pharmacol.- 2009. -V. 188. P. 295−317.
- Scholz C., Toth B., Santoso L., Kuhn C., Franz M., Mayr D., Jeschke U., Friese K., Schiessl B. Distribution and maturity of dendritic cells in diseases of insufficient placentation// Am J Reprod Immunol. 2008. — V.60, N 3. -P.238−244.
- Schreurs M.W.J., Eggert A.O.A, de Boer A.J., Vissers J.L.M., van Hall T.,
- Offringa R., Figdor C.G., Adema G.J. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model// Cancer Research. 2000. — V.60. — P. 6995−7001.
- Schuler T., Quin Z., Ibe S., Noben-Trauth N., Blankenstein T. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice// J. Exp. Med .- 1999. V.189. — P. 803−810.
- Seavey M.M., Mosmann T.R. Immunoregulation of fetal and anti-partenal immune response// Immunol. Res.- 2008.- Vol. 40.- P. 97−113.
- Segerer S.E., Meller N., van den Brandt J., Kapp M., Dietl J., Reichardt H.M., Rieger L., Kammerer U. Modulation of maturation and function of dendritic cells by female sex steroid hormones// Amer J Reprod Immunol.-2008.- V.60, N 1.- P.86−96.
- Sharpe A.H., Wherry E.J., Ahmed R., Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection// Nature Immunology. 2007. — V.8. — P. 239−245.
- Shojaeian J., Moazzeni S.M., Nikoo S., Bozorgmehr M., Nikougoftar M., Zarnani A.H. Immunosuppressive effect of pregnant mouse serum on allostimulatory activity of dendritic cells// J Reprod Immunol.- 2007. -V.75, N 1. P.23−31.
- Siegal F.P., Kadowaki N., Shodell M. The nature of the principal type I interferon-producing cells in human blood// Science-1999- V.284-P.1835−1837.
- Siegelin M., Reuss D., Habel A., Rami A., von Deimling A. Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells// Neuro- Oncology. -2009. V. l 1, N2.1. P.122−131.
- Simones T., Shepherd D., Moser M. Dendritic Cells //Comprehensive Toxicology. 2010-P.155−170.
- Soling A., Rainov N.G. Dendritic cell therapy of primary brain tumors// Mol Med. 2001. — V.7. — P. 659−667.
- Sozzani S., Allavena P., Vecchi A., Mantovani A. Chemokines and dendritic cells traffic// J.Immunol. 2000 — V.20. — P. 151−160.
- Steinman R.M., Dodhapkar M. Active immunization against cancer with dendritic cells: the near future // Int. J. Cancer. 2001 .- V. 94.- P. 459173.
- Straub R.H., Scholmerich J., Zietz B.Z. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases-substitutes of adrenal and sex hormones // Rheumatol. 2000. — V.59. -P.108−118.
- Strunk, D., Rappersberger, K., Egger, C., Strobl, H., Kromer, E., Elbe, A., Maurer, D., Stingl, G. Generation of human dendritic cell/Langerhans cells from circulating CD34-hematopoietic progenitor cells// Blood. 1996. -V.87.-P. 1292−1302.
- Suss, G., Shortman. K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis// J. Exp. Med. 1996. — V. 183. — P. 1789−1796.
- Suzuki T., Suzuki N., Daynes R.A., Engleman E.G. Dehydroepiandrosterone enhances IL-2 production and cytotoxic effectorfunction of human T cells// Clin Immunol Immunopathol. 1991. — V.61. -P.202 -211.
- Svane I.M., Nikolajsen K., Walter M.R., Buus S., Gad M., Claesson M.H., Pedersen A.E. Characterization of monocytes-derived dendritic cells maturated with IFN-a// Scand.J. of Immunol. 2006. — V.63. — P.217−222.
- Tabata N., Tagami H., Terui T. Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis// Arch Dermatol Res. 1997. — V.289. — N7. — P.410−414.
- Thurnher M., Zelle-Reiser C., Ramoner R., Bartsch G., Holtl L. The disabled dendritic cell//FASEB J.- 2001. -V. 15. P. 1054−1091
- Timmerman J.M. Immunotherapy for lymphomas// Hematology.- 2003.- V. 7. p.444−455.
- Tschoep K.E., Noessner E. Understand tolerogenic dendritic cells //Blood. -2007.- V. 109.-P 3616.
- Valone F.H., Small E., MacKenzie M., BurchP., LacyM., PeshwaM.V., Laus R. Dendritic cell-based treatment of cancer: closing in on a cellular therapy// Cancer J. 2001. — V. ½. — P.53−61.
- Van Kooyk Y., Geijtenbeek T.B. A novel adhesion pathway that regulatesdendritic cell trafficking and T-cell interactions// Immunol.Rev. 2002. -V.186. -P.47−59.
- Vanderheyde N., Vandenabeele P., Goldman M., Willems F. Distinct mechanisms are involved in tumoristatic and tumoricidal activities of monocyte-derived dendritic cells// Immunol Lett.- 2004.- V.91.- P.99−101.
- Vuckovic S, Kim M, Khalil D., Turtle C. J, Crosbie G. V, Williams N, Brown L. Granulocyte colonystimulatingfactor increases CD123hi blood dendritic cells withaltered CD62L and CCR7 expression// Blood.-2003.- V.101. -P.2314−2317.
- Waggoner A.S. Fluorescent probes for cytometry// In: Melamed M.R., Lindmo T., Mendelsohn M.L. (eds) Flow cytometry and sorting. Second edition. Wiley-Liss, Inc., 1990. P. 209−225.
- Wang F-S., Xing L-X., Liu M-X, Zhu C-L., Liu H-G., Wang H-F, Lei Z-Y. Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection// Wold J. Gastroenterol.- 2001.- V. 7.- P.537−541.
- Wesa A.K., Storkus W.J., Killer dendritic cells: mechanisms of action and therapeutic implications for cancer// Cell Death & Differentiation.- 2008.-V. 15.- P.51−57.
- Wilkinson P.C., Liew F.Y. Chemoattraction of human blood T lymphocytes by interleukin-15// J. Exp.Med. 1995.-V. 181. — P. 1255−1259.
- Wolf A.J., Linas B., Trevejo-Nunez G.J., Kincaid E., Tamura T., Takatsu K., Ernst J.D. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo// J. Immunol.- 2007.-V.179.-P.2509−2519.
- Woltman A.M., van Kooten G. Functional modulation of dendritic cells to suppress adaptive immune responses// J. Leukoc. Biol-2003. V.73. -P.428−441.
- Wong, K.A., Rodriguez A. Plasmodium infection and endotoxicshock induce the expansion of regulatory dendritic cells// J. Immunol.- 2008. -V. 180.-P.716−726.
- Yamanaka R., Yajima N., Abe T., Tsuchiya N., HommaJ., Narita M., Takahashi M., Tanaka R. Dendritic cell-based glioma immunotherapy // Int. J. Oncol.- 2003.- V. 23.- P.5−15.
- Yamazaki S., Bonito A.J., Spisek R., Dhodapkar M., Inaba K., Steinman
- R.M. Dendritic cells are specialized accessory cells along withTGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheralFoxp3 precursors// Blood.-2007.-V.l 10.-P.4293−4302.
- Yang L., Carbone D.P. Tumor-host immune interactions and dendritic cell dysfunction// Adv Cancer Res. 2004. — V.92. — P. 13−27.
- Yang R., Xu D. Zhang A., Gruber A. Immature dendritic cells kill ovarian carcinoma cells by a FAS/FASL pathway, enabling them to sensitize tumor-specific CTLs// International Jurna7 of Cancer. 2007. — V.94(3). — P. 407 413.
- Yu J., Liu G., Ying H., Yong W.H., Black K.L. Wheeler C.J. Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma.// Cancer Research. -2004. V. 64. — P. 4973−4979.
- Yu J.S., Wheeler C.J., Zeltzer P.M. Dendritic cell immunotherapy for patients with glioblastoma multiforme and anaplastic astrocytoma// Proc Am Assoc Cancer Res. 2001. — P. 274−275.
- Zhang Z., Tang L., Zhan R., Tong Y., Yao H., Du L. Immunotherapy ofintracranial G422 glioblastoma with dendritic cells pulsed with tumor extract or RNA// J Zhejiang Univ Sci. 2004. — V.5(10). — P. 1298−1303.
- Zheng B.J., Zhou J., Qu D., Siu K.L., Lam T.W., Lo H.Y., Lee S.S., Wen Y.M. Selective functional deficit in dendritic cell-T cell interaction is a crucial mechanism in chronic hepatitis B virus infection // J Viral Hepatitis.-2004.- V.11.-P.217−224.
- Zheng S.G., Wang J.H., Stohl W., Kim K.S., Gray J.D., Horwitz D.A. TGF-beta requires CTLA-4 early after T cell activation to induceFoxP3 and generate adaptive CD4+CD25+ regulatory cells// J. Immunol.-2006. -V.176.-P. 3321−3329.
- Zhu K, Shen Q, Ulrich M, Zheng M. Human monocyte-derived dendritic cells expressing both chemotactic cytokines IL-8, MCP-1, RANTES and their receptors, and their selective migration to these chemokines. //Chin Med J (Engl). 2000.-V. 113.-P. 1124−1128.
- Zhu K. J, Shen Q. Y, Zheng M., Mrowietz U. Effects of calcitriol and its analogues on interaction of MCP-1 and monocyte derived dendritic cells in vitro// Acta Pharmacol Sin. 2001. — V 22. — P.62−65.
- Zou W., Borvak J., Marches F., Wei S., Galanaud P., Emilie D., Curiel T.J. Macrophage-derived dendritic cells have strong Thl-polarizing potential mediated by beta-chemokines rather than IL-12// J. Immunol. 2000. -V.165. -P.4388−4396.